NK cell therapy is an advanced technology designed to enhance the immune system and support cancer prevention by leveraging the body's natural defenses. At Bright Cell Healthcare Institute we are offers an NK cell therapy program that lasts approximately 3-4 weeks at its FDA-registered facility in Irvine, California, USA.

Program Overview:

1. Blood Collection (Autologous Source)
• The patient provides their own blood for NK cell therapy.
2. Processing & NK Cell Expansion
• The collected blood undergoes a processing and cell culture phase to expand NK cells.
• Complete quality control tests are conducted to ensure the potency and safety of the expanded NK cells.
3. NK Cell Infusion
• The activated NK cells are administered intravenously in a controlled medical setting.
• The infusion can be performed as a single dose or multiple doses over several days, depending on the treatment plan.

This autologous NK cell therapy is designed to enhance the patient's immune system and target abnormal cells with high precision by leveraging the body's natural defenses.

For more details, please contact your regional Bright Cell Healthcare Institute service provider.